Detection and Characterization of Polioviruses

Methods in Molecular Biology

Volumn 665, Issue , 2011, Pages 233-256

  Martin, Javier ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

AFP surveillance; CPE; Global Polio Eradication Initiative; Infectious dose; Oral polio vaccine; Poliovirus; Sucrose gradient; VP1 capsid protein

Indexed keywords

VIRUS RNA;

ARTICLE; CULTURE TECHNIQUE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; POLIOMYELITIS VIRUS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SEROTYPING;

CELL CULTURE TECHNIQUES; HUMANS; NEUTRALIZATION TESTS; POLIOVIRUS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROTYPING;

EID: 79955836642     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-817-1_14     Document Type: Chapter

References (17)

1. Aylward, R.B., Hull, H.F., Cochi, S.L., Sutter, R.W., Olive, J.M., and Melgaard, B. (2000) Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ 78, 285–297.
2. Balanant, J., Guillot, S., Candrea, A., Delpeyroux, F., and Crainic, R. (1991) The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184, 645–654.
3. Dömök, I. and Magrath, D.I. (1979) Guide to Poliovirus Isolation and Serological Techniques. WHO Offset Publication No. 46.
4. Felsenstein, J. (2000) PHYLIP: Phylogeny Inference Package, Version 3.6a3 (Computer Program). Department of Genetics, University of Washington, Seattle (Distributed by the author).
5. Hovi, T. and Stenvik, M. (1994) Selective isolation of poliovirus in a recombinant murine cell line expressing the human poliovirus receptor gene. J Clin Microbiol 32, 1366–1368.
6. Kew, O.M., Sutter, R.W., de Gourville, E.M., Dowdle, W.R., and Pallansch, M.A. (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 5, 587–635.
7. Koike, S., Taya, C., Aoki, J., Matsuda, Y., Ise, I., Takeda, H., Matsuzaki, T., Amanuma, H., Yonekawa, H., and Nomoto, A. (1994) Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene – influence of the transgene expression on pathogenesis. Arch Virol 139, 351–363.
8. Martin, J. (2006) Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals 34, 117–122.
9. Mendelsohn, C.C., Wimmer, E., and Racaniello, V.R. (1989) Cellular receptor for poliovirus molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell 56, 855–865.
10. Minor, P.D. (1992) The molecular biology of poliovaccines. J Gen Virol 73, 3065–3077.
11. Pipkin, P.A., Wood, D.J., Racaniello, V.R., and Minor, P.D. (1993) Characterisation of L cells expressing the human poliovirus receptor for the specific detection of poliovirus in vitro. J Virol Methods 41, 333–340.
12. Poyry, T., Stenvik, M., and Hovi, T. (1988) Viruses in sewage waters during and after a poliomielitis outbreak. Appl Environ Microbiol 54, 371–374.
13. Salemi, M. and Vandamme, A-M. (2004) The Phylogenetic Handbook. Cambridge University Press, Cambridge.
14. World Health Organization (2002) Recommendations for the Production and Control of Poliomyelitis Vaccine (Oral). Fiftieth Report No. 904. WHO Expert Committee on Biological Standardization, Geneva, pp. 31–93.
15. World Health Organization (2003) Guidelines for Environmental Surveillance of Poliovirus Circulation. WHO/ IVB/03.03. World Health Organization, Geneva.
16. World Health Organization (2004) Polio Laboratory Manual, 4th Edn. WHO/ IVB/04.10. World Health Organization, Geneva.
17. World Health Organization (2004) Laboratory Safety Manual, 3rd Edn. WHO/CDS/CSR/ LYO/2004.11. World Health Organization, Geneva.